MedTech Acquisition Corp (MTAC) Financials

$11.34

$1.78 (18.67%)

As on 10-Aug-2023 16:00EDT

Market cap

$84 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

226.8

P/B Ratio

1.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	4.06	2.75	3.04	--	--	--
Operating Profit (EBIT)	-4.06	-2.75	-3.04	-0.11	--	--
Other Income	3.55	8.86	7.81	--	--	--
Profit before Tax	-0.51	6.11	4.77	-0.11	--	--
Provision for Tax	0.61	0.57	-0.06	--	--	--
Profit after Tax (Net Income)	-1.13	5.54	4.77	-0.11	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-1.13	5.54	4.77	-2.13	--	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-3.07	6.53	233.28	243.16	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	9.28	11.15	16.19	8.75	--	--
Current Liabilities	6.03	2.50	1.06	0.10	--	--
Total Liabilities	18.27	20.19	250.53	252.01	--	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	12.08	19.83	250.01	250.00	--	--
Current Assets	0.16	0.36	0.53	2.01	--	--
Total Assets	18.27	20.19	250.53	252.01	--	--
Total Debt*	3.33	2.37	0.54	--	--	--
Net Current Assets	-5.87	-2.14	-0.53	1.90	--	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-2.74	-1.74	-2.03	--	--
Cash Flow from Investing Activities	--	233.20	0.06	-750.00	--	--
Cash from Financing Activities	--	-230.51	0.54	756.04	--	--
Net Cash Inflow / Outflow	--	-0.05	-1.13	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	4.56	2.00	--	--	--
ROE (%)	--	4.62	2.00	--	--	--
ROA (%)	-0.83	4.09	1.90	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-31.78	62.55	61.06	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	63.02	9.69	-834.23	--	--	--
Net Profit Growth (%)	-2,161.78	16.19	4,631.85	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	226.80	--	--	--	--	--
Price / Book Value	1.31	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-124.12	2.05	23.15	--	--	--
Close Price ($)	10.48	10.03	9.88	--	--	--
High Price ($)	11.03	10.68	11.18	--	--	--
Low Price ($)	9.84	8.99	9.45	--	--	--
Market Cap ($ Cr)	83.86	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.36	0.00	--	--	--
Short term debt to equity ratio	-1.08	0.16	--	--	--	--
Current Ratio	0.03	0.14	0.50	19.46	--	--
Quick Ratio	0.03	--	--	--	--	--
Interest Coverage	0.94	-0.31	-47.51	--	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.